112th Congress
Washington, DC – Congresswoman Rosa L. DeLauro (CT-3), Ranking Member on the Labor, Health, and Human Services Appropriations Subcommittee, called on the Inspector General of the Department of Health & Human Services to review Medicare physician reimbursement rates and their impact on access to drugs for cancer patients.
Dear Inspector General Levinson:
I write to ask that you review the adequacy of the reimbursement rates established in the Medicare Prescription Drug, Improvement, and Modernization Act (MMA) of 2003 and their affect on physician practices' ability to obtain drugs and biologicals for the treatment of cancer patients.
Goal is to Provide Americans with Easy to Read, Easy to Understand Information on Health Insurance
WASHINGTON, D.C. — Congresswoman Rosa L. DeLauro (D-CT) and Senator Jay Rockefeller (D-WV) today asked three federal agencies to insist on strong rules so that consumers can easily understand their health coverage and determine the best insurance for themselves and their families. They also urged the Administration to reject calls from the insurance industry and others who are already trying to weaken the regulations.
Washington, DC – Congresswoman Rosa L. DeLauro (CT-3) released the following statement in response to the Joint Select Committee on Deficit Reduction's failure to reach a deal today.
New Haven, CT – Congresswoman Rosa L. DeLauro (CT-3) released the following statement on Sikorsky's announcement of additional layoffs in Connecticut.
New Haven, CT – Congresswoman Rosa L. DeLauro (CT-3) released the following statement on Sikorsky's announcement of additional layoffs in Connecticut.
Washington, DC – Congresswoman Rosa L. DeLauro (CT-3) released the following statement in response to the Joint Select Committee on Deficit Reduction's failure to reach a deal today.
Washington, DC – Congresswoman Rosa L. DeLauro (CT-3), Ranking Member on the Labor, Health, and Human Services Appropriations Subcommittee, issued the following statement following the Food and Drug Administration's decision to revoke the approval of the cancer drug Avastin due to its potentially dangerous side effects.
Congresswoman DeLauro had previously called for action on this medication in December of 2010, when the FDA had originally made their recommendation to remove the breast cancer indication from the label for Avastin.
Washington, DC – Congresswoman Rosa L. DeLauro (CT-3), Ranking Member on the Labor, Health, and Human Services Appropriations Subcommittee, issued the following statement following the Food and Drug Administration's decision to revoke the approval of the cancer drug Avastin due to its potentially dangerous side effects.
Congresswoman DeLauro had previously called for action on this medication in December of 2010, when the FDA had originally made their recommendation to remove the breast cancer indication from the label for Avastin.
VOW to Hire Heroes Act will create jobs, put veterans to work
Washington, DC – Congresswoman Rosa L. DeLauro (CT-3), Ranking Member on the Labor, Health, and Human Services Appropriations Subcommittee, praised the passage of the Veterans Opportunity to Work (VOW) to Hire Heroes Act today. This legislation will provide veterans with job training opportunities and businesses with tax credits to encourage them to hire service members and veterans with service-related disabilities as proposed in President Obama’s American Jobs Act.